/Antidepressiva 03 Exam
,Multiple-choice questions
Question 1
Which expression preserves the stated quality-control requirement?
Error Analysis and Corrective Actions: Troubleshooting strategies for systematic and random analytical
errors, calibration drift, and ____
A. z-score calculations
B. reagent lot variations
C. Performance Criteria
D. deviation limits
Correct Answer: B
Full Explanation: Data Evaluation, Statistical Processing, and Reporting: Error Analysis and Corrective
Actions: Troubleshooting strategies for systematic and random analytical errors, calibration drift, and
reagent lot variations. The required expression is “reagent lot variations”; it completes the specific
association described, rather than substituting a different concept.
Question 2
A proposed description contains an incorrect bracketed expression. Which replacement makes the
description accurate?
Calibrators and Internal Standards: Use of stable isotope-labeled internal standards (IS) to correct for
[high-concentration samples] and ionization suppression in mass spectrometry
A. method validations
B. matrix effects
C. high-concentration samples
D. Analytical Measurement Range
Correct Answer: B
Full Explanation: Analytical Methodology and Quantitative Techniques: Calibrators and Internal Standards:
Use of stable isotope-labeled internal standards (IS) to correct for matrix effects and ionization suppression
in mass spectrometry. The required expression is “matrix effects”; it completes the specific association
described, rather than substituting a different concept.
Question 3
A proposed description contains an incorrect bracketed expression. Which replacement makes the
description accurate?
Ultra-High-Performance Liquid Chromatography (UHPLC) configurations and optimization [coupled]
Chromatography-Mass Spectrometry (GC-MS) method validations and derivatization requirements where
applicable
A. coupled
B. parametersGas
C. specificity
D. Tandem
Correct Answer: B
Full Explanation: Analytical Methodology and Quantitative Techniques: Ultra-High-Performance Liquid
Chromatography (UHPLC) configurations and optimization parametersGas Chromatography-Mass
Spectrometry (GC-MS) method validations and derivatization requirements where applicable. The required
expression is “parametersGas”; it completes the specific association described, rather than substituting a
different concept.
Record 3833 2
,Multiple-choice questions
Question 4
A proposed description contains an incorrect bracketed expression. Which replacement makes the
description accurate?
Therapeutic window monitoring and management of [Selective Serotonin Reuptake Inhibitor]
A. dose-dependent extrapyramidal side effects
B. phenothiazine derivative with piperazine structure
C. Selective Serotonin Reuptake Inhibitor
D. primary active chiral metabolite
Correct Answer: A
Full Explanation: Core Analytes and Pharmacological Specifications: Therapeutic window monitoring and
management of dose-dependent extrapyramidal side effects. The required expression is “dose-dependent
extrapyramidal side effects”; it completes the specific association described, rather than substituting a
different concept.
Question 5
Which term is associated with the following description?
Identification of hemolysis, lipemia, icterus, and exogenous contamination impacting quantitative recovery
A. Sample Matrix Specifications
B. Sample Stability and Storage
C. Pre-Analytical Interference Factors
D. frozen storage
Correct Answer: C
Full Explanation: Pre-Analytical Phase and Specimen Management: Pre-Analytical Interference Factors:
Identification of hemolysis, lipemia, icterus, and exogenous contamination impacting quantitative recovery.
The required expression is “Pre-Analytical Interference Factors”; it completes the specific association
described, rather than substituting a different concept.
Question 6
Which expression is needed to make this description accurate?
Frequency and Certification ____: Semi-annual evaluations with 12-month certificate validity upon successful
fulfillment of target criteria
A. pharmacologists
B. diagnostics
C. Cycle
D. medications
Correct Answer: C
Full Explanation: Program Scope and Administrative Framework: Frequency and Certification Cycle:
Semi-annual evaluations with 12-month certificate validity upon successful fulfillment of target criteria. The
required expression is “Cycle”; it completes the specific association described, rather than substituting a
different concept.
Record 3833 3
, Multiple-choice questions
Question 7
Which choice restores the intended meaning of the following description?
Core Analytes and Pharmacological Specifications — Analytical separation from structural co-analogs and
____
A. Pharmacological classification
B. temperature equilibration
C. interference mitigation
D. steady-state concentration
Correct Answer: C
Full Explanation: Core Analytes and Pharmacological Specifications: Analytical separation from structural
co-analogs and interference mitigation. The required expression is “interference mitigation”; it completes
the specific association described, rather than substituting a different concept.
Question 8
Which expression completes the analytical or procedural description?
Reconstitution and ____: Standard operating procedures (SOPs) for rehydration, mixing time, and
temperature equilibration of proficiency samples
A. Preparation
B. fulfillment
C. quantification
D. impacting
Correct Answer: A
Full Explanation: Pre-Analytical Phase and Specimen Management: Reconstitution and Preparation:
Standard operating procedures (SOPs) for rehydration, mixing time, and temperature equilibration of
proficiency samples. The required expression is “Preparation”; it completes the specific association
described, rather than substituting a different concept.
Question 9
A proposed description contains an incorrect bracketed expression. Which replacement makes the
description accurate?
[Desmethylfluoxetine], elimination half-lives, and steady-state concentration monitoring
A. Norfluoxetine
B. Pharmacokinetics
C. Desmethylfluoxetine
D. reference
Correct Answer: B
Full Explanation: Core Analytes and Pharmacological Specifications: Pharmacokinetics, elimination
half-lives, and steady-state concentration monitoring. The required expression is “Pharmacokinetics”; it
completes the specific association described, rather than substituting a different concept.
Record 3833 4